SIM
ARCT icon

Spark Investment Management’s Arcturus Therapeutics ARCT Stock Holding History

Spark Investment Management’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-3,771
Closed -$165K – 766
2015
Q4 		$165K Sell
3,771
-7,705
-67% -$347K 0.02% 605
2015
Q3 		$485K Buy
11,476
+8,033
+233% +$423K 0.06% 380
2015
Q2 		$156K Buy
+3,443
New +$158K 0.02% 560
2015
Q1 		– Sell
-2,232
Closed -$58K – 703
2014
Q4 		$58K Buy
+2,232
New +$71K 0.01% 629
2014
Q2 		– Sell
-3,843
Closed -$487K – 633
2014
Q1 		$487K Buy
+3,843
New +$570K 0.08% 364

Other funds holding ARCT

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Spark Investment Management's ARCT Position: Q1 2016 in Review

Spark Investment Management sold out of Arcturus Therapeutics (ARCT) in Q1 2016, closing a stake of 3,771 shares — an estimated $165K sold.

Spark Investment Management first reported a position in ARCT in Q1 2014 and held it in 5 quarters. The position peaked at $487K in Q1 2014. 46 funds tracked by Wall St. Rank hold ARCT as of Q1 2016.

  • Spark Investment Management reported no remaining Arcturus Therapeutics position as of Q1 2016 after selling out during the quarter.
  • Spark Investment Management sold 3,771 Arcturus Therapeutics shares in Q1 2016, an estimated $165K.
  • Spark Investment Management first reported a position in Arcturus Therapeutics in Q1 2014 and held it in 5 quarters.
  • Spark Investment Management's Arcturus Therapeutics position peaked at $487K in Q1 2014.
  • 46 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q1 2016.

Based on Spark Investment Management's 13F filing for Q1 2016, filed 12 May 2016.